Differences in Nephrotoxicity of Intravenous Bisphosphonates for the Treatment of Malignancy- Related Bone Disease

Publisher： Karger

E-ISSN： 2296-5262|29|11|534-540

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.11, 2006-10, pp. : 534-540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nephrotoxicity associated with the use of intravenous colistin

By Santamaria Cecilia   Mykietiuk Analia   Temporiti Elena   Stryjewski Martin   Herrera Fabian   Bonvehi Pablo  

Scandinavian Journal of Infectious Diseases, Vol. 41, Iss. 10, 2009-01 ,pp. : 767-769

Informa Healthcare

Access to resources Recommend Favorite

Role of intravenous immunoglobulin in the treatment of Kawasaki disease

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 21, Iss. 1, 2018-01 ,pp. : 64-69

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bone health-related factors and the use of bisphosphonates in community setting—15-year follow-up study

By Sirola J.   Salovaara K.   Rikkonen T.   Kärkkäinen M.   Tuppurainen M.   Jurvelin J.   Honkanen R.   Kröger H.  

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 255-264

Springer Publishing Company

Access to resources Recommend Favorite

Gender Differences in the Treatment of Cerebrovascular Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 48, Iss. 7, 2000-07 ,pp. : 741-745

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of a Therapy‐Resistant Severely Pruritic Skin Eruption of Malignancy‐Associated Dermatomyositis with High‐Dose Intravenous Immunoglobulin

By  

THE JOURNAL OF DERMATOLOGY, Vol. 23, Iss. 5, 1996-05 ,pp. : 340-343

John Wiley & Sons Inc

Access to resources Recommend Favorite